Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir/r Monotherapy vs Standard Therapy in HIV-1 Patients (MONOI)
NCT00421551Phase 3Completed
- Sponsor
- ANRS
- Start
- Mar 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of darunavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by ANRS. Primary endpoint: Proportion of patients with virological success at Week 48. Started Mar 2007; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00421551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421551.